Choosing a course is one of the most important decisions you'll ever make! View our courses and see what our students and lecturers have to say about the courses you are interested in at the links below.
Each year more than 4,000 choose NUI Galway as their University of choice. Find out what life at NUI Galway is all about here.
About NUI Galway
About NUI Galway
Since 1845, NUI Galway has been sharing the highest quality teaching and research with Ireland and the world. Find out what makes our University so special – from our distinguished history to the latest news and campus developments.
Colleges & Schools
Colleges & Schools
NUI Galway has earned international recognition as a research-led university with a commitment to top quality teaching across a rang of key areas of expertise.
Business & Industry
Guiding Breakthrough Research at NUI Galway
We explore and facilitate commercial opportunities for the research community at NUI Galway, as well as facilitating industry partnership.
- Alumni, Friends & Supporters
At NUI Galway, we believe that the best learning takes place when you apply what you learn in a real world context. That's why many of our courses include work placements or community projects.
Dr Teck Wee Boo MB,BAO,BCH, BMedSc, FRCPath, MRCP
Peer Reviewed Journals
|Boo TW, Lynch N, Cryan B, Kearney PJ. (2003) 'Mastoiditis presenting as an acute abdomen with features of Lemierre's syndrome'. Ir Med J, 96 (9):277-278. [Details]|
|Boo TW, Hone R, Hurley J. (2003) 'Erysipelothrix rhusiopathiae endocarditis: a preventable zoonosis?'. Ir J Med Sci, 172 (2):81-82. [Details]|
|Boo TW, Hone R, Sheehan G, Walsh M. (2003) 'Isolation of linezolid-resistant Enterococcus faecalis'. J Hosp Infect, 53 (4):312-313. [Details]|
|Boo TW, Cryan B, O'Donnell A, Fahy G. (2005) 'Prosthetic valve endocarditis caused by Veillonella parvula'. J Infect, 50 (1):81-83. [Details]|
|Boo TW, O'reilly B, O'leary J, Cryan B. (2005) 'Candidaemia in an Irish tertiary referral hospital: epidemiology and prognostic factors'. Mycoses, 48 (4):251-259. [Details]|
|Boo TW, Walsh F, Crowley B. (2006) 'First report of OXA-23 carbapenemase in clinical isolates of Acinetobacter species in the Irish Republic'. J Antimicrob Chemother, 58 (5):1101-1102. [Details]|
|Roche C, Boo TW, Walsh F, Crowley B. (2008) 'Detection and molecular characterisation of plasmidic AmpC beta-lactamases in Klebsiella pneumoniae isolates from a tertiary-care hospital in Dublin, Ireland'. Clin Microbiol Infect, 14 (6):616-618. [Details]|
|Boo TW, Crowley B. (2009) 'Detection of blaOXA-58 and blaOXA-23-like genes in carbapenem-susceptible Acinetobacter clinical isolates: should we be concerned?'. J Med Microbiol, 58 ((Pt 6)):839-841. [Details]|
|Boo TW, Walsh F, Crowley B. (2009) 'Molecular characterization of carbapenem-resistant Acinetobacter species in an Irish university hospital: predominance of Acinetobacter genomic species 3'. J Med Microbiol, 58 ((Pt 2):209-216. [Details]|
|Grundmann H, Livermore DM, Giske CG, Canton R, Rossolini GM, Campos J, Vatopoulos A, Gniadkowski M, Toth A, Pfeifer Y, Jarlier V, Carmeli Y, (2010) 'CNSE Working Group.Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts'. Euro Surveill pii: 19711, 15 (46). [Details]|
|O'Connell K, Boo TW, Keady D, Niriain U, O'Donovan D, Commane M, Faherty C, Cormican M. (2011) 'Use of palivizumab and infection control measures to control an outbreak of respiratory syncytial virus in a neonatal intensive care unit confirmed by real-time polymerase chain reaction'. J Hosp Infect, 77 (4):338-342. [Details]|